JP2015508099A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2015508099A5 JP2015508099A5 JP2014558733A JP2014558733A JP2015508099A5 JP 2015508099 A5 JP2015508099 A5 JP 2015508099A5 JP 2014558733 A JP2014558733 A JP 2014558733A JP 2014558733 A JP2014558733 A JP 2014558733A JP 2015508099 A5 JP2015508099 A5 JP 2015508099A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- pharmaceutically acceptable
- conr
- conditions
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261601101P | 2012-02-21 | 2012-02-21 | |
| US61/601,101 | 2012-02-21 | ||
| PCT/US2012/070252 WO2013126132A1 (en) | 2012-02-21 | 2012-12-18 | Cyclic diaminopyrimidine derivatives |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2015508099A JP2015508099A (ja) | 2015-03-16 |
| JP2015508099A5 true JP2015508099A5 (cg-RX-API-DMAC7.html) | 2016-12-08 |
| JP6059260B2 JP6059260B2 (ja) | 2017-01-11 |
Family
ID=47459190
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014558733A Expired - Fee Related JP6059260B2 (ja) | 2012-02-21 | 2012-12-18 | 環状ジアミノピリジン誘導体 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9073944B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2817306B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP6059260B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN104254531B (cg-RX-API-DMAC7.html) |
| AR (1) | AR090103A1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2012370450B2 (cg-RX-API-DMAC7.html) |
| CA (1) | CA2865040C (cg-RX-API-DMAC7.html) |
| ES (1) | ES2552518T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL233986A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2013126132A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2955612C (en) | 2014-07-18 | 2022-05-17 | Advaxis, Inc. | Combination of a pd-1 antagonist and a listeria-based vaccine for treating prostate cancer |
| RS61996B1 (sr) | 2016-12-22 | 2021-07-30 | Calithera Biosciences Inc | Kompozicije i postupci za inhibiranje aktivnosti arginaze |
| BR112021018168B1 (pt) | 2019-03-21 | 2023-11-28 | Onxeo | Composição farmacêutica, combinação e kit compreendendo uma molécula dbait e um inibidor de quinase para o tratamento de câncer |
| KR20220098759A (ko) | 2019-11-08 | 2022-07-12 | 인쎄름 (엥스띠뛰 나씨오날 드 라 쌍떼 에 드 라 흐쉐르슈 메디깔) | 키나제 억제제에 대해 내성을 획득한 암의 치료 방법 |
| WO2021148581A1 (en) | 2020-01-22 | 2021-07-29 | Onxeo | Novel dbait molecule and its use |
| US20230099804A1 (en) * | 2020-02-14 | 2023-03-30 | Salk Institute For Biological Studies | Macrocyclic ulk1/2 inhibitors |
| AU2021357717A1 (en) * | 2020-10-05 | 2023-06-08 | Merck Patent Gmbh | Lmp7-selective inhibitors for the treatment of blood disorders and solid tumors |
| JP7556310B2 (ja) * | 2021-02-26 | 2024-09-26 | スズキ株式会社 | 電動車両 |
| KR20240021751A (ko) | 2021-03-27 | 2024-02-19 | 티알엑스 바이오사이언시스 리미티드 | 치료제의 생체 이용률이 향상된 조성물 |
| WO2023025912A1 (en) | 2021-08-25 | 2023-03-02 | Alesta Therapeutics BV | Use of gcn2 inhibitors in treating cancer |
| IL315617A (en) * | 2022-03-14 | 2024-11-01 | Trx Biosciences Ltd | Preparations with improved bioavailability of drugs and their uses |
| WO2024017251A1 (zh) * | 2022-07-18 | 2024-01-25 | 江苏恒瑞医药股份有限公司 | 抑制并诱导egfr降解的大环类化合物、其制备方法及其在医药上的应用 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| WO1997030035A1 (en) | 1996-02-13 | 1997-08-21 | Zeneca Limited | Quinazoline derivatives as vegf inhibitors |
| IL125954A (en) | 1996-03-05 | 2003-06-24 | Zeneca Ltd | Quinazoline derivatives, processes for their preparation, pharmaceutical compositions containing them and use thereof in the manufacture of medicaments having an antiangiogenic and/or vascular permeability reducing effect |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| NZ522074A (en) | 2000-05-31 | 2004-06-25 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
| EP1301498A1 (en) | 2000-07-07 | 2003-04-16 | Angiogene Pharmaceuticals Limited | Colchinol derivatives as angiogenesis inhibitors |
| WO2002004434A1 (en) | 2000-07-07 | 2002-01-17 | Angiogene Pharmaceuticals Limited | Colchinol derivatives as vascular damaging agents |
| ZA200501536B (en) * | 2002-08-14 | 2006-10-25 | Vertex Pharma | Protein kinase inhibitors and uses thereof |
| CA2533774A1 (en) * | 2003-07-29 | 2005-02-10 | Irm Llc | Compounds and compositions as protein kinase inhibitors |
| PT1656372E (pt) * | 2003-07-30 | 2013-06-27 | Rigel Pharmaceuticals Inc | Métodos para o tratamento ou prevenção de doenças autoimunes com compostos de 2,4-pirimidinadiamina |
| GB0321710D0 (en) * | 2003-09-16 | 2003-10-15 | Novartis Ag | Organic compounds |
| CA2631875A1 (en) * | 2005-12-06 | 2007-10-04 | Rigel Pharmaceuticals, Inc. | Formulation of insoluble small molecule therapeutics in lipid-based carriers |
| SI1984357T1 (sl) * | 2006-02-17 | 2014-02-28 | Rigel Pharmaceuticals, Inc. | Spojine 2,4-pirimidindiamina za zdravljenje ali preventivo avtoimunih bolezni |
| EP2078026B1 (en) * | 2006-11-21 | 2012-01-04 | Rigel Pharmaceuticals, Inc. | Prodrug salts of 2, 4-pyrimidinediamine compounds and their uses |
| MX2011002470A (es) | 2008-09-08 | 2011-04-05 | Merck Patent Gmbh | Pirimidinas macrociclicas como inhibidores de aurora cinasa. |
-
2012
- 2012-12-18 JP JP2014558733A patent/JP6059260B2/ja not_active Expired - Fee Related
- 2012-12-18 AU AU2012370450A patent/AU2012370450B2/en not_active Ceased
- 2012-12-18 US US14/379,625 patent/US9073944B2/en active Active
- 2012-12-18 CN CN201280070330.7A patent/CN104254531B/zh not_active Expired - Fee Related
- 2012-12-18 CA CA2865040A patent/CA2865040C/en active Active
- 2012-12-18 EP EP12808646.9A patent/EP2817306B1/en active Active
- 2012-12-18 ES ES12808646.9T patent/ES2552518T3/es active Active
- 2012-12-18 WO PCT/US2012/070252 patent/WO2013126132A1/en not_active Ceased
-
2013
- 2013-02-21 AR ARP130100516 patent/AR090103A1/es unknown
-
2014
- 2014-08-06 IL IL233986A patent/IL233986A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2015508099A5 (cg-RX-API-DMAC7.html) | ||
| JP2015529657A5 (cg-RX-API-DMAC7.html) | ||
| US9783513B2 (en) | STAT3 inhibitors and their anticancer use | |
| JP2015508086A5 (cg-RX-API-DMAC7.html) | ||
| JP2015535831A5 (cg-RX-API-DMAC7.html) | ||
| JP2014513729A5 (cg-RX-API-DMAC7.html) | ||
| JP2012507522A5 (cg-RX-API-DMAC7.html) | ||
| ES2755424T3 (es) | Análogos de salinomicina que contienen nitrógeno, síntesis y utilización contra células troncales cancerosas y paludismo | |
| JP2012072150A5 (cg-RX-API-DMAC7.html) | ||
| ES2989922T3 (es) | Compuestos de carborano y métodos de uso de los mismos | |
| WO2019177975A1 (en) | Antibiotics effective for gram-negative pathogens | |
| RU2013148146A (ru) | Производные адамантила | |
| CN111727042A (zh) | 微管蛋白抑制剂 | |
| JP2014517051A (ja) | ジュウテリウム富化４−ヒドロキシ−５−メトキシ−ｎ，１−ジメチル−２−オキソ−ｎ−［（４−トリフルオロ−メチル）フェニル］−１，２−ジヒドロキノリン−３−カルボキサミド | |
| US20250281515A1 (en) | Carborane compounds, carborane analogs, and methods of use thereof | |
| JP2020002165A (ja) | ジピコリルアミン誘導体及びそれらの薬学的使用 | |
| US9340501B2 (en) | Marinopyrrole derivatives as anticancer agents | |
| EP4429702A1 (en) | Compositions comprising amino lipid compounds and methods of making and use thereof | |
| JPWO2020102576A5 (cg-RX-API-DMAC7.html) | ||
| US8871983B2 (en) | Lipid compounds for suppression of tumorigenesis | |
| JPWO2020102100A5 (cg-RX-API-DMAC7.html) | ||
| WO2019102054A1 (es) | Análogos no glicosídicos de alfa-galactosilceramida como activadores de células nkt | |
| JPWO2023121971A5 (cg-RX-API-DMAC7.html) | ||
| US20250289837A1 (en) | Mitochondriotropic heteroaryl benzamide potassium channel kv1.3 inhibitors | |
| CA2914439A1 (en) | Pharmaceutical compositions |